drugset / Trial / NCT07425509

Evaluation of a Stannous Fluoride Dentifrice for Control of Oral Malodor

NCT07425509

Completed 49 enrolled Church & Dwight Company, Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

This single-center, randomized, double-blind, two-treatment crossover clinical study evaluated the safety and efficacy of a stannous fluoride-containing dentifrice compared with a sodium fluoride control dentifrice for the control of intrinsic oral malodor. Adult subjects brushed twice daily with each product during separate treatment periods following standardized wash-out periods. Oral malodor was assessed using trained organoleptic judges applying a validated Odor Intensity (OI) scale at baseline and multiple post-treatment time points.

Timeline

Start
2024-09-09
Primary completion
2024-11-04
Completion
2024-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium fluoride Unknown 0.243 % Oral
Subject stannous fluoride Small molecule 0.454 % Oral

Indications

No indication recorded.